Volume 45, Issue 4 (12-2021)                   Research in Medicine 2021, 45(4): 76-82 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mousavi A, Mohammadzadeh M, Asadian A. Trend analysis of the antibiotic categories’ sales in Iran during 2002-2017. Research in Medicine. 2021; 45 (4) :76-82
URL: http://pejouhesh.sbmu.ac.ir/article-1-2914-en.html
Corresponding author, Ph. D Candidate at Department of Pharmacoeconomics and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran , a.mousavi@sbmu.ac.ir
Abstract:   (487 Views)
Background: One of the thriving pharmaceutical sectors is the antibiotic market, which is widely used to cure infections. However, the irrational use of antibiotics can cause microbial resistance. Due to the increasing consumption of antibiotics in Iran and the world, this pharmaceutical class's market research provides excellent insight for healthcare providers and is therefore of great importance. The present study is a practical and time-series study using 16 years of antibiotic sales data.
Materials and methods:The digital sales of antibiotics from 2002 to 2017 were obtained from the Iranian Ministry of Health. Then, the sales patterns of each antibiotic category were examined.
 Findings:In 1396, 9.54% of the pharmaceutical market in Iran belonged to antibiotics. The highest sales were for Penicillins (38.87%) and Cephalosporins (25.92%), and the lowest sales for Carbapenems and Glycopeptides (0.33%) categories. In general, Cephalosporin, Carbapenem, Lincosamides, Glycopeptides, Macrolides, and Quinolones had growing sales patterns during the 16 years studied, while Aminoglycosides, Sulfonamides, and anti-tubular medicines had declining sales patterns. 
Conclusion:The use of antibiotics is showing an increasing trend in Iran. Also, there is a concern about increase in the use of broad-spectrum antibiotics, such as Cefixime, Cefepime, Azithromycin, and Meropenem. Therefore, there is a need to establish regulatory policies for antibiotic prescription and consumption and proper management in this area.
Full-Text [PDF 4033 kb]   (120 Downloads)    
Type of Study: Original | Subject: Pharmacy: (Pharmacology, Pharmaceutical Economy)
Received: 2020/07/3 | Accepted: 2021/09/4 | Published: 2022/02/9

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This Journal is licensed under a Creative Commons Attribution 4.0 International License  | Research in Medicine

Designed & Developed by : Yektaweb